. extension to our growing group of specialist electronics repair and overhaul businesses, and we look forward to working with Maurice, Rena and the team at Electronix to deliver further success to the business.". #AMCO.

. and acquisitive growth strategy, but also marks Amcomri's first acquisition outside of the UK, as we continue to roll out our proven 'Buy, Improve, Build' model. "Following the previous acquisitions of TP Matrix and Etrac, Electronix provides an exciting and logical. .

Mark O'Neill, Investment Director of Amcomri, commented:. "We are very pleased to confirm our first acquisition in Ireland and our second acquisition this year since our admission to AIM in December 2024. The acquisition of Electronix not only strengthens our ambitious organic. .

🦾Strong reputation and established customer relationships across diverse sectors.🏦Significant repeat revenue characteristics across a quality customer base.📈Synergy and expansion potential. ✅ Proven track record of acquiring and enhancing specialist electronics businesses.

. ending divisions position the Group well as it looks to further support UK business requiring funding for business-critical equipment through Asset Finance or working capital solutions through Invoice Finance.". #TIME.

. Hard Asset lending by 249%. Strong demand for both product sets has continued to be experienced in the first months of the new financial year which began on 1 June 2025. "As such, the significant headroom provided by these larger and more flexible facilities across all. .

James Roberts, Chief Financial Officer, commented:. "I am delighted that the Group has put in place substantial funding facilities as we embark on our new three-year growth plan. The previous plan, from June 2021 to May 2025, saw Invoice Finance lending increase by 170% and. .

Time Finance extended funding facilities now exceed £250m, providing fuel for future growth. ➡️ Renewed and enhanced across a diversified panel of eight long-standing and supportive funding partners. ➡️ Funding headroom over £95m.

. happiness and every success in his next chapter.". #TRX.

"I would like to congratulate David on a well-earned retirement. David's contributions and accomplishments have been instrumental in the Company's growth and success over the past several years. David will be a missed presence among the Tissue Regenix team, but we wish him much. .

Daniel Lee, CEO of Tissue Regenix, commented: "We are pleased to appoint Brandon Largent as interim CFO. The Group will undergo a seamless transition as we benefit from Brandon's working knowledge of Tissue Regenix and his previous experiences in financial leadership roles.".

#ABDX.

➡️@Abingdon_Health announces new contract win . 💰Expected value of c. $2.5m.✒️Signed MSA with leading global pharmaceutical company for companion diagnostic lateral flow test.📜Full CDMO service contract.✅Project expected to take approx 24 months

A successful open day is underway at the Company headquarters of @TristelGlobal in Snailwell, Cambridgeshire. Shareholders can listen to a presentation by the management and a US customer using Tristel ULT; and take a tour of the facility.

Tristel plc (AIM: #TSTL) hosted a successful Capital Markets Day at @Cavendish_plc for institutional investors and analysts @TristelGlobal

🔗

☑️@Renalytix (AIM: #RENX) announces services contract with Joslin Diabetes Centre & Major Pharma Partner. 🔬Clinical utility of 21 proteins linked to end-stage kidney disease.📊Data to guide future drug trials.✅Exclusive use of JKP™ tech expands RENX pharma service offering

RT @time_finance: We are proud to have helped the British Business Bank reach a landmark milestone of £2.5 billion of lending under the Gro….

🔗

.@hVIVO_UK  (AIM: #HVO) announces appointment of Shaun Chilton as Non-Executive Chair, subject to completion of due diligence. ➡️Intended to join Board on 1 Sept '25. ➡️Over 30 years of sector-relevant experience in private and public businesses.➡️Previously CEO of Clinigen Group.